Comparison of Video Laryngoscopy Versus Direct Laryngoscopy for Orotracheal Intubation Among Adults in Emergency Department

April 9, 2024 updated by: Rony Maharjan, Patan Academy of Health Sciences

This is an open-label, single center, prospective, randomized, comparative, intervention study.

The goal of this study is to compare the success rate of video laryngoscopy vs direct laryngoscopy for first pass oro tracheal intubation. The other question it aims to answer are:

  1. To assess the adverse events during video laryngoscopy
  2. To assess the adverse events during direct Laryngoscopy
  3. To compare the first pass success rate of DL vs VL according to demographic profile (age and sex)

Study Overview

Detailed Description

All consecutive patients presenting in Emergency medicine room requiring intubation, will be recruited in this study after taking informed written consent from the patients' family, excluding those falling in exclusion criteria. Direct laryngoscopy will be done by Mackintosh Laryngoscope with blade no 3 or 4. Video Laryngoscopy will be done by Mcgrath Mac Video Laryngoscope in respective groups. Intubations will be done by ER physicians and Emergency fellows of Emergency department. The total number of required sample size will be calculated and the obtained number will be divided in a group of 21 with block of 6 each. After randomizing the group and the block from a computerized software, a total of 21 envelope will be prepared in a consecutive manner and the patient will be intubated as per the pre decided blocks. All the patients in emergency who require intubation and falling into the inclusion criteria will be assessed. Informed written consent will be taken from the patient's family explaining that they will be a part of study and either of the laryngoscopy method will be used in them. Informed consent will be taken by one of the investigators, (ER physicians and emergency medicine fellow) who will be performing intubations in them.Inclusion criteria-

  • Age 18 years
  • Patient requiring orotracheal intubation
  • Those who give written informed consent

Exclusion criteria-

  • Pregnancy
  • Intubations done by medical officers

Randomization-

  • The consecutive patients will be assigned numbers serially from one.
  • Block randomization of the patients in two arms will be done by using computerized software.

A total of 63 patients in each arm with total 126 patients will be included in the study. Blocks of 6 will be taken with total 21 groups. With using the software, random group will be selected and intubations will be done accordingly.

Demographic and clinical profile of patients in both arms will be recorded. Two treatment arms-

  • Arm A- Orotracheal intubation done by Direct Laryngoscopy
  • Arm B- Orotracheal intubation done by Video Laryngoscopy

Outcomes Primary- First pass success of direct laryngoscopy in oro tracheal intubation First pass success of video laryngoscopy in oro tracheal intubation

Secondary- Complications rates between two methods. Use of alternative methods for ventilation or oxygenation between two methods Better visualization of Cormack-Lehane grading between two methods

Study Type

Interventional

Enrollment (Estimated)

126

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age 18 years
  2. Patient requiring orotracheal intubation
  3. Those who give written informed consent

Exclusion Criteria:

  1. Pregnancy
  2. Intubations done by medical officers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Direct Laryngoscopy
All participants who are intubated from Direct laryngoscopy is enrolled in this arm.
DL
Experimental: Video Laryngoscopy
All participants who are intubated from Video laryngoscopy is enrolled in this arm.
VL

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First pass success of direct laryngoscopy in oro tracheal intubation
Time Frame: 1 year
success of oro tracheal intubation during DL
1 year
First pass success of video laryngoscopy in oro tracheal intubation
Time Frame: 1 year
success of oro tracheal intubation during VL
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications rates between two methods.
Time Frame: 1 year
rate of complication during intubation via DL or VL will be noted
1 year
Use of alternative methods for ventilation or oxygenation between two methods
Time Frame: 1 year
use of alternative methods during intubation via DL or VL will be noted
1 year
Better visualization of Cormack-Lehane grading between two methods
Time Frame: 1 year
better visualization of cormack lehane grading during intubation via DL or VL will be noted
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rony Maharjan, MD, Patan Academy of Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

May 1, 2025

Study Registration Dates

First Submitted

March 18, 2024

First Submitted That Met QC Criteria

March 22, 2024

First Posted (Actual)

March 25, 2024

Study Record Updates

Last Update Posted (Actual)

April 11, 2024

Last Update Submitted That Met QC Criteria

April 9, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • drs2402021836

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on To Compare Success Rate of Video Laryngoscopy vs Direct Laryngoscopy

Clinical Trials on Oro Tracheal Intubation by DL

3
Subscribe